SS Innovations International (SSII) Liabilities and Shareholders Equity (2016 - 2026)
SS Innovations International recorded quarterly Liabilities and Shareholders Equity of $90.5 million in Q1 2026, up 21.99% quarter-over-quarter from $74.2 million in Q4 2025, and up 42.69% year-over-year from $63.5 million in Q1 2025.
SS Innovations International's Liabilities and Shareholders Equity history runs 11 years deep, the most recent figure standing at $90.5 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 42.69% year-over-year to $90.5 million; the TTM figure through Mar 2026 stood at $304.3 million (up 68.57% YoY), while the FY2025 annual figure was $74.2 million, up 75.12% from the prior year.
- Liabilities and Shareholders Equity came in at $90.5 million for Q1 2026 at SS Innovations International, up from $74.2 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $90.5 million in Q1 2026 to a low of $279336.0 in Q2 2022.
- A 5-year average of $35.7 million and a median of $35.2 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity slumped 36.52% in 2022 and surged 4349.77% in 2023, its largest moves.
- SS Innovations International's Liabilities and Shareholders Equity stood at $7.0 million in 2022, then soared by 351.48% to $31.5 million in 2023, then surged by 34.49% to $42.4 million in 2024, then jumped by 75.12% to $74.2 million in 2025, then increased by 21.99% to $90.5 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $90.5 million, $74.2 million, and $69.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn | 90.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90.55 Mn |
| Dec 31, 2025 | 74.23 Mn |
| Sep 30, 2025 | 69.58 Mn |
| Jun 30, 2025 | 69.98 Mn |
| Mar 31, 2025 | 63.46 Mn |
| Dec 31, 2024 | 42.39 Mn |
| Sep 30, 2024 | 39.02 Mn |
| Jun 30, 2024 | 35.67 Mn |
| Mar 31, 2024 | 35.20 Mn |
| Dec 31, 2023 | 31.52 Mn |
| Sep 30, 2023 | 28.16 Mn |
| Jun 30, 2023 | 12.43 Mn |
| Mar 31, 2023 | 5.47 Mn |
| Dec 31, 2022 | 6.98 Mn |
| Sep 30, 2022 | 1.65 Mn |
| Jun 30, 2022 | 279,336.00 |
| Mar 31, 2022 | 367,396.00 |
| Dec 31, 2021 | 428,607.00 |
| Sep 30, 2021 | 334,401.00 |
| Jun 30, 2021 | 440,038.00 |
| Mar 31, 2021 | 466,635.00 |
| Dec 31, 2020 | 317,870.00 |
| Sep 30, 2020 | 51,661.00 |
| Jun 30, 2020 | 65,750.00 |
| Mar 31, 2020 | 79,812.00 |
| Dec 31, 2019 | 132,524.00 |
| Sep 30, 2019 | 187,893.00 |
| Jun 30, 2019 | 207,228.00 |
| Mar 31, 2019 | 164,734.00 |
| Dec 31, 2018 | 145,434.00 |
| Sep 30, 2018 | 216,413.00 |
| Jun 30, 2018 | 284,777.00 |
| Mar 31, 2018 | 410,479.00 |
| Dec 31, 2017 | 509,962.00 |
| Sep 30, 2017 | 569,679.00 |
| Jun 30, 2017 | 178,077.00 |
| Dec 31, 2016 | 292,232.00 |